Successful Delivery Of A Medicinal Product Containing The Active Substance Nivolumab As Part Of A Non-Commercial Clinical Trial: "Efficacy And Tolerability Of N-Avd Compared To Brecadd In Patients With Advanced Hodgkin Lymphoma (N-Brave)"